IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹249 Cr | ₹235 Cr | ₹119 Cr | ₹93 Cr | ₹70 Cr |
What is the latest Contingent Liabilities ratio of IPCA LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹249 Cr |
| Mar2025 | ₹235 Cr |
| Mar2024 | ₹119 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹70 Cr |
How is Contingent Liabilities of IPCA LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹249 Cr | 6.10 | |
| Mar2025 | ₹235 Cr | 97.16 | |
| Mar2024 | ₹119 Cr | 27.48 | |
| Mar2023 | ₹93 Cr | 34.12 | |
| Mar2022 | ₹70 Cr | - | |
Compare Contingent Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,981.4 Cr | 0.3% | 11.5% | 47.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 0.3% |
11.5% |
47.1% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses